We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$16.8B
AUM Growth
+$1.95B
Cap. Flow
+$1.49B
Cap. Flow %
8.85%
Top 10 Hldgs %
30.31%
Holding
2,964
New
179
Increased
2,266
Reduced
433
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$118M
2
AAPL icon
Apple
AAPL
+$96.6M
3
NVDA icon
NVIDIA
NVDA
+$91.2M
4
AMZN icon
Amazon
AMZN
+$67.2M
5
META icon
Meta Platforms (Facebook)
META
+$38.6M

Sector Composition

Rank Sector Weight
1 Technology 30.48%
2 Financials 11.78%
3 Healthcare 11.37%
4 Consumer Discretionary 10.49%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
2201
Voyager Therapeutics
VYGR
$198M
$214K ﹤0.01%
27,035
+8,766
+48% +$73.5K
LMNR icon
2202
Limoneira
LMNR
$250M
$214K ﹤0.01%
10,265
+964
+10% +$19.4K
HDSN
2203
Hudson Technologies
HDSN
$239M
$213K ﹤0.01%
24,205
+5,029
+26% +$48.7K
SIGA icon
2204
SIGA Technologies
SIGA
$207M
$212K ﹤0.01%
27,976
+2,607
+10% +$21.2K
HVT icon
2205
Haverty Furniture Companies
HVT
$450M
$212K ﹤0.01%
8,376
+909
+12% +$26.3K
TWI icon
2206
Titan International
TWI
$438M
$212K ﹤0.01%
28,584
+3,281
+13% +$31.1K
BBW icon
2207
Build-A-Bear
BBW
$474M
$211K ﹤0.01%
8,360
+691
+9% +$19.5K
PACB icon
2208
Pacific Biosciences
PACB
$357M
$211K ﹤0.01%
154,159
+32,858
+27% +$66.4K
AURA icon
2209
Aura Biosciences
AURA
$791M
$210K ﹤0.01%
27,785
+11,076
+66% +$81.1K
NWPX icon
2210
NWPX Infrastructure Inc
NWPX
$1.11B
$210K ﹤0.01%
6,181
+691
+13% +$23.4K
SVRA icon
2211
Savara
SVRA
$1.08B
$210K ﹤0.01%
52,024
+12,213
+31% +$54.3K
FUBO icon
2212
FuboTV Inc
FUBO
$296M
$209K ﹤0.01%
14,046
+1,396
+11% +$22.3K
ALRS icon
2213
Alerus Financial
ALRS
$844M
$209K ﹤0.01%
10,655
+929
+10% +$18.3K
OABI icon
2214
OmniAb
OABI
$499M
$209K ﹤0.01%
55,676
+5,249
+10% +$23.9K
ALNT icon
2215
Allient
ALNT
$1.86B
$209K ﹤0.01%
8,255
+795
+11% +$22.8K
ITOS
2216
DELISTED
iTeos Therapeutics
ITOS
$208K ﹤0.01%
14,043
+1,365
+11% +$19.6K
TRDA icon
2217
Entrada Therapeutics
TRDA
$290M
$208K ﹤0.01%
14,598
+2,904
+25% +$41.3K
NVEC icon
2218
NVE Corp
NVEC
$563M
$208K ﹤0.01%
2,784
+261
+10% +$20.4K
DHIL
2219
DELISTED
Diamond Hill
DHIL
$208K ﹤0.01%
1,477
+137
+10% +$20.6K
FIVN icon
2220
FIVE9
FIVN
$2.53B
$208K ﹤0.01%
4,709
+316
+7% +$16.4K
NRC icon
2221
NRC Health Common Stock
NRC
$471M
$207K ﹤0.01%
9,038
+1,799
+25% +$55.5K
CABA icon
2222
Cabaletta Bio
CABA
$442M
$207K ﹤0.01%
27,714
+9,399
+51% +$115K
OSUR icon
2223
OraSure Technologies
OSUR
$277M
$207K ﹤0.01%
48,542
+5,254
+12% +$26.7K
SYRE icon
2224
Spyre Therapeutics
SYRE
$8.98B
$207K ﹤0.01%
+8,788
New +$296K
ADV icon
2225
Advantage Solutions
ADV
$423M
$206K ﹤0.01%
2,563
+637
+33% +$59.3K

Similar funds

MetLife Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, MetLife Investment Management held 2,964 positions worth $16.8B, up 13% from $14.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $1.49B of net new capital in Q2 2024, opening 179 new positions and adding to 2,266 existing holdings. Its largest new stake was GE Vernova: 73,079 shares worth $12.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92.7M trimmed.

  • MetLife Investment Management's largest Q2 2024 buy was GE Vernova: 73,079 shares worth $12.5M.
  • MetLife Investment Management added most to Microsoft in Q2 2024, an estimated $118M increase.
  • MetLife Investment Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.7M.
  • MetLife Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.4M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $16.8B portfolio in Q2 2024.
  • MetLife Investment Management opened 179 new positions and closed 84 in Q2 2024.
  • MetLife Investment Management's portfolio value rose 13% quarter-over-quarter to $16.8B.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.